BRKR vs OXIG.L
BRKR: Bruker is a global leader in high-performance analytical instrumentation and diagnostic solutions for life sciences and materials research, enabling structural biology, drug discovery, and scientific innovation at molecular levels. OXIG.L: Oxford Instruments designs and manufactures high-performance tools and systems that allow researchers and industry leaders to analyze and manipulate matter at the atomic and molecular level.
Side-by-side fundamentals
| Metric | BRKR | OXIG.L | Edge |
|---|---|---|---|
| Price as of 2026-08-05 close | $52.47 | £27.08 | |
| Market cap as of 2026-08-06 | $8.0B | n/a | |
| PEG as of 2026-08-06 | 1.92 | n/a | |
| Net margin as of 2026-08-06 | -0.3% | n/a | |
| Gross margin as of 2026-08-06 | +46.7% | n/a | |
| Operating margin as of 2026-08-06 | +0.8% | n/a | |
| ROE as of 2026-08-06 | -0.5% | n/a | |
| ROA as of 2026-08-06 | -0.2% | n/a | |
| Debt / equity as of 2026-08-06 | 0.68 | n/a | |
| Revenue growth (YoY) as of 2026-08-06 | +0.4% | n/a | |
| Revenue CAGR (3y) SEC XBRL | +10.7% | n/a | |
| Dividend yield as of 2026-08-06 | +0.4% | n/a | |
| Dividend streak (yrs) SEC XBRL | 5 | n/a | |
| Beta as of 2026-08-06 | 1.22 | n/a | |
| 1-year return as of 2026-08-05 close | +63.6% | +51.5% | BRKR higher |
Fundamentals: market data, as of 2026-08-06. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-05.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.